EXPRESSION AND UPTAKE OF PARATHYROID HORMONE RELATED PEPTIDE IN HEPATOCELLULAR CARCINOMA
- Combined hepatocellular-cholangiocarcinoma producing parathyroid hormone-related protein: report of a case. Matsumoto, Michinori; Wakiyama, Shigeki; Shiba, Hiroaki; Gocho, Takeshi; Misawa, Takeyuki; Ishida, Yuichi; Itsubo, Mariko; Suzuki, Masafumi; Yanaga, Katsuhiko // Surgery Today;Aug2014, Vol. 44 Issue 8, p1577
Combined hepatocellular-cholangiocarcinoma (CHCC) is an uncommon form of primary liver cancer. A 57-year-old man was readmitted to our hospital for treatment of recurrent CHCC, 12 months after central bisegmentectomy and 4 months after limited hepatic resection. Magnetic resonance imaging (MRI)...
- Hypercalcemic Encephalopathy in a Patient with Hepatocellular Carcinoma. Pere Tudela; Berta Soldevila; Josep MÃ²dol; Eugeni DomÃ¨nech // Digestive Diseases & Sciences;Nov2007, Vol. 52 Issue 11, p3296
AbstractÃ‚Â Ã‚Â Cirrhotic patients with hepatocellular carcinoma (HCC) frequently develop hepatic encephalopathy. Metabolic etiology of encephalopathy is less often considered in these patients. Although paraneoplastic hypercalcemia may be associated with several malignant tumors, it...
- Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin. Min, Lihua; Ji, Yuan; Bakiri, Latifa; Qiu, Zhixin; Cen, Jin; Chen, Xiaotao; Chen, Lingli; Scheuch, Harald; Zheng, Hai; Qin, Lunxiu; Zatloukal, Kurt; Hui, Lijian; Wagner, Erwin F. // Nature Cell Biology;Apr2013, Vol. 15 Issue 4, p440
A correction to the article "Liver Cancer Initiation Is Controlled by AP-1 Through SIRT6-dependent Inhibition of Survivin," published in a previous issue of "Nature Cell Biology," is presented.
- Reduced p21WAF1/CIP1protein expression is predominantly related to altered p53 in hepatocellular carcinomas. Shi, Y-Z; Hui, A-M; Takayama, T; Li, X; Cui, X; Makuuchi, M // British Journal of Cancer;7/1/2000, Vol. 83 Issue 1, p50
To investigate the relationship between the expression of p21[SUPWAF1/ClP1]protein and p53 status and the possible role of the two proteins in hepatocellular carcinomas (HCCs), we examined the expression of p21[SUPWAF1/ClP1]and p53 immunohistochemically in 81 tumours from 65 patients with...
- Markedly elevated alpha feto protein levels without hepatocellular carcinoma. Cheema, Ahmad W; Hirschtritt, Todd; VanThiel, David H // American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS138
An abstract of the article "Markedly Elevated Alpha Feto Protein Levels Without Hepatocellular Carcinoma," by Ahmad W. Cheema, Todd Hirschtritt, and David H. VanThiel is presented.
- Effects of Alendronate on Bone Metastases and Hypercalcemia After Surgery for Hepatocellular Carcinoma. Ohnishi, Takamasa; Takeda, Eiji; Yogita, Shiro; Miyake, Hidenori; Kinoshita, Takafumi; Terashima, Yoshiyasu; Matsumoto, Toshio; Tashiro, Seiki // Japanese Journal of Clinical Oncology;Sep2000, Vol. 30 Issue 9
Investigates the effects of alendronate, a bisphosphonate compound, in patients with hypercalcemia due to bone metastasis of hepatocellular carcinoma. Decrease in corrected serum calcium levels, alpha-fetoprotein levels and bone pain of the two patients after treatment; Alleviation of pain due...
- Proteomic-based approach for the identification of tumor markers associated with hepatocellular carcinoma. Shalhoub, Philip; Kern, Sarah; Girard, Sophie; Beretta, Laura // Disease Markers;2001, Vol. 17 Issue 4, p217
There is increasing evidence for an immune response to cancer in humans, demonstrated in part by the identification of autoantibodies to tumor antigens. The identification of panels of tumor antigens that elicit a humoral response may have utility in cancer screening, diagnosis or in...
- Recombinant human activated protein C in a liver transplant recipient in the immediate postoperative period. REWARI, V.; MILAN, Z. B.; ATTIA, M.; DAVIES, M. // Anaesthesia & Intensive Care;Jul2011, Vol. 39 Issue 4, p771
A letter to the editor about the use of recombinant human activated protein C (rhAPC) in a 63-year-old man with a history of end-stage alcoholic liver disease and co-existing hepatocellular carcinoma, type 2 diabetes and previous spontaneous bacterial peritonitis, is presented.
- The expression of PD-L1 APE1 and P53 in hepatocellular carcinoma and its relationship to clinical pathology. Berretta, Massimiliano; Stanzione, B.; Di Francia, R.; Tirelli, U. // European Review for Medical & Pharmacological Sciences;2015, Vol. 19 Issue 22, p4207
A letter to the editor is presented in response to the article "The Expression of PD-L1 APE1 and P53 in Hepatocellular Carcinoma and Its Relationship to Clinical Pathology" by Kan and Dong that was published in a 2015 issue.